Lof Sanne, Rajak Rushda, Vissers Frederique L I M, Korrel Maarten, Bateman Adrian, Verheij Johanna, Verbeke Caroline, Cataldo Ivana, Besselink Marc G, Abu Hilal Mohammed
Department of Surgery, Southampton University Hospital NHS Foundation Trust.
Department of Pathology, Southampton University Hospital NHS Foundation Trust.
J Vis Exp. 2020 Feb 1(156). doi: 10.3791/60343.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant cancers. A minority (20%) of PDACs are found in the pancreatic body and tail. Accurate pathology assessment of the pancreatic specimen is essential for providing prognostic information and it may guide further treatment strategies. The recent 8 edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) staging system for pancreatic tumors has incorporated significant changes to tumor (pT) stage, which is predominantly based on tumor size. This change emphasizes the importance of careful block selection. Owing to the greater prevalence of tumors in the head of the pancreas, efforts are made to standardize the assessment of pancreatoduodenectomy specimens. However, consensus regarding the macroscopic assessment of distal (i.e., left) pancreatectomy specimens is lacking. The DIPLOMA approach includes the standardized measurement of pancreas and other resected organs, inking of relevant surgical margins and anatomical surfaces without removing covering layers of fat, measurement of tumor size (for T-stage), together with assessment of splenic vessel involvement (and other organs if present). All relevant margins are assessed, and relevant blocks are selected to confirm these parameters microscopically. The current protocol describes a standardized approach to the macroscopic assessment of distal pancreatectomy specimens. This approach was developed during several meetings with pathologists and surgeons during the preparation phase for an international multicenter trial (DIPLOMA, ISRCTN44897265), which focuses on radicality of distal pancreatectomy for pancreatic ductal adenocarcinoma. This standardized approach can be instrumental in the design of studies and will uniform reporting on the outcomes of distal pancreatectomy. The described technique is used in the DIPLOMA trial for pancreatic ductal adenocarcinoma but may also be useful for other indications.
胰腺导管腺癌(PDAC)是最致命的恶性肿瘤之一。少数(20%)的PDAC发生在胰体和胰尾。胰腺标本的准确病理评估对于提供预后信息至关重要,并且可能指导进一步的治疗策略。美国癌症联合委员会/国际癌症控制联盟(AJCC/UICC)最近的第8版胰腺肿瘤分期系统对肿瘤(pT)分期进行了重大修改,该分期主要基于肿瘤大小。这一变化强调了仔细选择组织块的重要性。由于胰腺头部肿瘤的患病率更高,人们努力规范胰十二指肠切除术标本的评估。然而,对于远端(即左侧)胰腺切除术标本的宏观评估缺乏共识。DIPLOMA方法包括对胰腺和其他切除器官进行标准化测量,在不去除脂肪覆盖层的情况下对相关手术切缘和解剖表面进行标记,测量肿瘤大小(用于T分期),以及评估脾血管受累情况(如有其他器官受累也进行评估)。评估所有相关切缘,并选择相关组织块进行显微镜检查以确认这些参数。本方案描述了一种对远端胰腺切除术标本进行宏观评估的标准化方法。这种方法是在国际多中心试验(DIPLOMA,ISRCTN44897265)的准备阶段,与病理学家和外科医生多次会议期间制定的,该试验侧重于胰腺导管腺癌远端胰腺切除术的根治性。这种标准化方法有助于研究设计,并将使远端胰腺切除术的结果报告更加统一。所描述的技术用于DIPLOMA胰腺导管腺癌试验,但也可能对其他适应症有用。